Connection

PAUL LING to RNA, Messenger

This is a "connection" page, showing publications PAUL LING has written about RNA, Messenger.
Connection Strength

0.279
  1. The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation. PLoS Pathog. 2015 May; 11(5):e1004910.
    View in: PubMed
    Score: 0.078
  2. Promyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells. J Virol. 2013 Nov; 87(22):12151-7.
    View in: PubMed
    Score: 0.069
  3. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One. 2011; 6(11):e27271.
    View in: PubMed
    Score: 0.061
  4. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J Virol. 2005 Apr; 79(7):4492-505.
    View in: PubMed
    Score: 0.039
  5. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J Virol. 1994 Sep; 68(9):5375-83.
    View in: PubMed
    Score: 0.019
  6. Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia. J Infect Dis. 2004 Jul 15; 190(2):396-9.
    View in: PubMed
    Score: 0.009
  7. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol. 1995 Nov; 15(11):6150-9.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.